World Health Organization Sounds Concern Over Acute Scarcity of Obesity Medications

Less than a tenth of individuals that would benefit from obesity jabs like Wegovy have access to them, states the global health agency as it issues its initial recommendations on the therapies.

Considering over a billion individuals worldwide now living with obesity, it is advocating for more widespread and fairer availability to this class of drugs.

According to estimates, over two billion could be living with obesity by 2030 without intervention.

"The new guidelines affirms that excess weight is a long-term condition that can be treated with comprehensive and ongoing treatment," remarked its chief Tedros Adhanom Ghebreyesus.

Substantial prices, constrained manufacturing, and supply-chain constraints are significant hurdles to universal access to the injections that can assist patients in reducing substantial weight, explains the agency.

Weight-Loss Drug Supply Crisis

Despite the current most favorable case, the manufacturing of these medications could only cover about 100 million people – less than 10% of those who need them, as stated by the WHO.

The recommendation encourages nations and manufacturers to increase availability, by strategies like patent sharing.

The intellectual property rights on the active ingredient – the primary ingredient of a leading brand – is set to lapse in multiple countries in 2026.

The Way Weight-Loss Jabs Operate

These medications imitate a natural hormone to reduce digestion speed, suppress the appetite and boost feelings of fullness so individuals reduce food intake.

Individuals commonly start to lose weight after several weeks of starting on the regular doses.

Research indicates people may see weight return a year later of stopping the treatment, as their normal hunger come back.

To be overweight or obese raises your likelihood for developing diseases, such as diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity impacts people in all nations and was responsible for millions of fatalities worldwide in 2024, per the WHO.